CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 82 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2018. The put-call ratio across all filers is 3.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,000 | +150.0% | 1,800 | +80.0% | 0.00% | – |
| Q3 2019 | $4,000 | -80.0% | 1,000 | -65.2% | 0.00% | – |
| Q2 2019 | $20,000 | -79.2% | 2,870 | -79.3% | 0.00% | -100.0% |
| Q1 2019 | $96,000 | +9.1% | 13,850 | -8.0% | 0.00% | 0.0% |
| Q4 2018 | $88,000 | +131.6% | 15,050 | +201.0% | 0.00% | – |
| Q3 2018 | $38,000 | +2.7% | 5,000 | -16.7% | 0.00% | – |
| Q2 2018 | $37,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | -47.1% | 6,000 | -38.6% | 0.00% | -100.0% |
| Q4 2017 | $70,000 | +20.7% | 9,770 | +21.1% | 0.00% | 0.0% |
| Q3 2017 | $58,000 | +141.7% | 8,070 | +106.9% | 0.00% | – |
| Q2 2017 | $24,000 | -25.0% | 3,900 | 0.0% | 0.00% | – |
| Q1 2017 | $32,000 | +10.3% | 3,900 | +14.7% | 0.00% | – |
| Q4 2016 | $29,000 | +866.7% | 3,400 | +750.0% | 0.00% | – |
| Q3 2016 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |